TerminatedPHASE1, PHASE2NCT04614974
Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia
Studying Congenital laryngomalacia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Reema Padia
- Principal Investigator
- Reema Padia, MDDivision of Pediatric Otolaryngology, Children's Hospital of Pittsburgh
- Intervention
- Famotidine(drug)
- Enrollment
- 65 enrolled
- Eligibility
- All sexes
- Timeline
- 2020 – 2024
Study locations (1)
- UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04614974 on ClinicalTrials.gov